Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e408
JournalBlood cancer journal
StatePublished - Mar 25 2016
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this